[go: up one dir, main page]

ES471809A1 - Procedimiento para preparar derivados de naftaleno - Google Patents

Procedimiento para preparar derivados de naftaleno

Info

Publication number
ES471809A1
ES471809A1 ES471809A ES471809A ES471809A1 ES 471809 A1 ES471809 A1 ES 471809A1 ES 471809 A ES471809 A ES 471809A ES 471809 A ES471809 A ES 471809A ES 471809 A1 ES471809 A1 ES 471809A1
Authority
ES
Spain
Prior art keywords
formula
derivatives
piperazinotetraline
medicines
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES471809A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES471809A1 publication Critical patent/ES471809A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

Procedimiento para preparar derivados del naftaleno, de fórmula Ia **(Fórmula 1)** en donde R1'' es alcoxi de 1 a 4 átomos de carbono; R2'' y R3'', independientemente, son hidrógeno, o un grupo alcoxi de 1 a 4 átomos de carbono, o bien R1'' y R2'', juntas, son un grupo -0-CH2-0- caracterizado porque comprende reducir compuestos de fórmula II **(Fórmula 2)** en donde R1'', R2'', R3'' y A'' se definen como anteriormente, preferentemente por hidrogenación catalítica, en presencia de un disolvente orgánico inerte, a temperaturas entre 10 y 50ºC, preferentemente entre 20 y 30ºC; y si se desea se convierten los compuestos resultantes de fórmula Ia en sus sales de adición de ácido.
ES471809A 1977-07-18 1978-07-17 Procedimiento para preparar derivados de naftaleno Expired ES471809A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH886377 1977-07-18
CH1358377 1977-11-08

Publications (1)

Publication Number Publication Date
ES471809A1 true ES471809A1 (es) 1979-10-01

Family

ID=25703869

Family Applications (2)

Application Number Title Priority Date Filing Date
ES471809A Expired ES471809A1 (es) 1977-07-18 1978-07-17 Procedimiento para preparar derivados de naftaleno
ES479059A Expired ES479059A1 (es) 1977-07-18 1979-03-29 Procedimiento para preparar derivados del naftaleno.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES479059A Expired ES479059A1 (es) 1977-07-18 1979-03-29 Procedimiento para preparar derivados del naftaleno.

Country Status (17)

Country Link
US (1) US4308266A (es)
EP (1) EP0000395B1 (es)
JP (1) JPS5422383A (es)
AU (1) AU521642B2 (es)
CA (1) CA1131641A (es)
CY (1) CY1224A (es)
DE (1) DE2860410D1 (es)
DK (1) DK309678A (es)
ES (2) ES471809A1 (es)
FI (1) FI68821C (es)
HK (1) HK85184A (es)
IE (1) IE47129B1 (es)
IL (1) IL55153A (es)
IT (1) IT1105089B (es)
NZ (1) NZ187876A (es)
PH (1) PH17238A (es)
PT (1) PT68306A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590274A (en) * 1985-01-03 1986-05-20 E. I. Du Pont De Nemours And Company Antihypertensive 1-[bis-(substituted phenyl)methyl]-4[2-(1,2,3,4-tetrahydro-substituted naphthalen-1-ylidene)ethyl]piperazines
GB8615560D0 (en) * 1986-06-25 1986-07-30 Maggioni Farma Aminoalcohols
JPH01503777A (ja) * 1985-10-04 1989-12-21 マツジヨ‐ニ‐ウインスロツプ・ソチエタ・ペル・アチオニ 縮合脂環式アミノアルコール類
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
CA1335591C (en) * 1988-05-23 1995-05-16 James Arthur Nixon Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
US4988699A (en) * 1989-03-14 1991-01-29 Warner-Lambert Company Substituted tetrahydrobenzothiazoles as dopaminergic agents
GB8907865D0 (en) * 1989-04-07 1989-05-24 Wyeth John & Brother Ltd Tetrahydroquinoline derivatives
US5194439A (en) * 1990-04-06 1993-03-16 John Wyeth & Brother Limited N-(2,3-dihydro-1,4-benzodioxinyl)-N-substituted aminopyrido-fused cycloalkanes
GB2290790A (en) * 1994-06-30 1996-01-10 Merck & Co Inc Asymmetric synthesis of 6-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1190466B (de) * 1961-11-07 1965-04-08 Cassella Farbwerke Mainkur Ag Verfahren zur Herstellung von Piperazinderivaten
CA969955A (en) * 1970-07-20 1975-06-24 Rene Viterbo Dihydronaphthalene derivatives
US4018773A (en) * 1975-09-15 1977-04-19 E. R. Squibb & Sons, Inc. Phenylpiperazinotetrahydronaphthols and derivatives

Also Published As

Publication number Publication date
FI68821B (fi) 1985-07-31
IE781438L (en) 1979-01-18
AU3808678A (en) 1980-01-17
NZ187876A (en) 1981-02-11
CY1224A (en) 1984-04-06
PT68306A (fr) 1978-08-01
ES479059A1 (es) 1979-07-01
IL55153A (en) 1983-07-31
DK309678A (da) 1979-01-19
CA1131641A (en) 1982-09-14
HK85184A (en) 1984-11-16
IT7850272A0 (it) 1978-07-13
US4308266A (en) 1981-12-29
JPS5422383A (en) 1979-02-20
IT1105089B (it) 1985-10-28
EP0000395A1 (de) 1979-01-24
IL55153A0 (en) 1978-09-29
FI68821C (fi) 1985-11-11
EP0000395B1 (de) 1981-01-07
FI782202A7 (fi) 1979-01-19
AU521642B2 (en) 1982-04-22
IE47129B1 (en) 1983-12-28
DE2860410D1 (en) 1981-02-26
PH17238A (en) 1984-07-03

Similar Documents

Publication Publication Date Title
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ES8106696A1 (es) Procedimiento para la preparacion de bis-(hidroxialcohilami-das)de acidos 5-(n-alcohil-a-hidroxiacil-amino)-2,4,6-triyo-do-isoftalicos
ES8707547A1 (es) Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos
ES471809A1 (es) Procedimiento para preparar derivados de naftaleno
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES405983A1 (es) Procedimiento para la preparacion de derivados de fenileti-lamina fluoralcohilados.
ES8300711A1 (es) Un procedimiento para la preparacion de un derivado cis-4,5-disustituidos de imidazolidin-2-ona opticamente activo.
ES8507484A1 (es) Procedimiento de producir compuestos beta-lactamicos y similares
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
ES480671A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinazolina.
ES8306742A1 (es) "un procedimiento para la preparacion de 4-(4-imidazolil)-piridinas 2-sustituidas".
ES438044A1 (es) Procedimiento para preparar 2-amino-1, 3-tiazinas.
ES390163A1 (es) Procedimiento para la preparacion de amino-derivados de los acidos pirazolo (3,4-b) piridina-5-carboxilicos.
ES461691A1 (es) Un procedimiento para la preparacion de sales de compuestos.
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
ES8305327A1 (es) Procedimiento para preparar derivados de indol o de indolina.
ES476632A1 (es) Procedimiento para preparar derivados de anilida con susti--tucion heterociclica.
ES8104199A1 (es) Procedimiento de preparacion de nuevos derivados de benzoil-2 nitro-4 anilidas y sus sales
SE7812371L (sv) Forfarande for framstellning av fenoxialkanolaminderivat
ES8104806A1 (es) Un procedimiento para la preparacion de octahidro-1h-pirro- lo-(2,3g)isoquinolinas
ES8506601A1 (es) Un procedimiento para la preparacion de derivados de benzamida
ES8106156A1 (es) Un procedimiento para la preparacion de derivados de oxadia-zolotriazona
MX3153E (es) Procedimiento para la preparacion de 4 - fenil - imidazolinas sustituidas
MX3393E (es) Procedimiento para la preparacion de arilalcohilaminas
ES8201525A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20001009